Category: us corporate news

us corporate news

CECO Environmental Corp. 2025 Annual Report: Business Overview, Risk Factors, and Regulatory Disclosures

Minichart

March 3, 2026

CECO Environmental Corp. 2025 Annual Report: Key Highlights ...

Continue Reading 0

us corporate news

Amarin Corporation plc 2025 Annual Report: Company Overview, Financials, and SEC Filings

Minichart

March 3, 2026

Amarin Corporation plc 2025 Annual Report: Key Investor Insi...

Continue Reading 0

us corporate news

Lumexa Imaging Reports Strong 2025 Results, Announces 2026 Financial Guidance and Growth Highlights

Minichart

March 2, 2026

Lumexa Imaging Announces Robust Preliminary Q4 and Full Year...

Continue Reading 0

us corporate news

Teradata Corporation 8-K SEC Filing Summary – Director Changes, Company Details & XBRL Report (Feb 27, 2026)

Minichart

March 2, 2026

Teradata Corporation 8-K Filing: Board Changes and Potential...

Continue Reading 0

us corporate news

Macerich 2026 Business Update: Record Leasing, Growth Pipeline, and Asset Sales Progress

Minichart

March 2, 2026

Macerich Delivers Record Leasing Activity and Accelerates Pa...

Continue Reading 0

us corporate news

CareTrust REIT, Inc. 8-K Filing Summary for March 2, 2026 – SEC Disclosure, Address, and Common Stock Details

Minichart

March 2, 2026

CareTrust REIT, Inc. 8-K Filing – Key Details for Investors ...

Continue Reading 0

us corporate news

Zymeworks Secures $250 Million Non-Dilutive Royalty-Backed Financing from Royalty Pharma for Ziihera Royalties

Minichart

March 2, 2026

Zymeworks Secures \$250 Million Royalty-Backed Financing fro...

Continue Reading 0

us corporate news

Alaunos Therapeutics Reports Positive Preclinical Results for ALN1003, a Novel Non-Hormonal Oral Obesity Drug Candidate 1

Minichart

March 2, 2026

Alaunos Therapeutics Announces Promising Preclinical Results...

Continue Reading 0

us corporate news

Kairos Pharma Acquires Exclusive Worldwide Rights to AI-Designed EGFR Inhibitor CL-273, Expanding Lung Cancer Pipeline in $16.2 Billion Market 12

Minichart

March 2, 2026

Kairos Pharma Announces Strategic Acquisition of CL-273 ...

Continue Reading 0

us corporate news

United Therapeutics’ Ralinepag Achieves 55% Reduction in Clinical Worsening for Pulmonary Arterial Hypertension in Pivotal Phase 3 Trial

Minichart

March 2, 2026

United Therapeutics Reports Landmark Phase 3 Results for Ral...

Continue Reading 0

Category: us corporate news

Join Our Investing Seminar